Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of esomeprazole 20 mg capsule versus tablet in healthy Thai volunteers under fasting and fed conditions
TCTR20201125002Phase 4Not yet recruiting
- Sponsor
- Pharmacy Service Center, Faculty of Pharmacy, Chiang Mai University
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esomeprazole (2 arms), sponsored by Pharmacy Service Center, Faculty of Pharmacy, Chiang Mai University. Primary endpoints: Plasma esomeprazole AUC0-t under fasting conditions, Plasma esomeprazole AUC0-inf under fasting conditions and 4 more. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
esomeprazole
Beyond the preview
Go deeper on TCTR20201125002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20201125002.